Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Focalin XR, Focalin
Generic Name: Dexmethylphenidate
Dexmethylphenidate is a central nervous system stimulant. It is used in the treatment of attention-deficit/hyperactivity disorder (ADHD).
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| ADHD (Attention Deficit/Hyperactivity Disorder) | 12 | 4 |
|
|
|
||
| Problems concentrating | 12 | 4 |
|
|
|
||
| Fatigue | 9 | 1 |
|
||||
| Excessive daytime sleepiness (somnolence) | 2 | 0 | |||||
| Chronic Fatigue Syndrome | 2 | 1 |
|
||||
| Depressed mood | 2 | 1 |
|
See all 27 patients currently taking Dexmethylphenidate
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Dexmethylphenidate
| Stiffness/Spasticity | 1 | |
|---|---|---|
| Mania | 1 | |
| Heart rate increased | 1 | |
| Inability to sleep | 1 | |
| scattered as soon as I started taking it. | 1 | |
| out of it. | 1 | |
| See all 7 reported side effects ▼ | ||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 6 | ||
| Doctor's advice | 5 | ||
| Side effects too severe | 4 | ||
| Expense | 4 | ||
| Other | 2 | ||
| Change in health plan coverage | 2 | ||
| Not indicated | 1 |
See all 16 patients who’ve stopped taking Dexmethylphenidate
Adherence
Taking treatment as prescribed
Adherence of Dexmethylphenidate
Always |
10 | 91% |
|
|---|---|---|---|
Usually |
1 | 9% |
|
Sometimes |
0 | 0% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Dexmethylphenidate
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
0 | 0% |
|
A little |
2 | 18% |
|
Not at all |
9 | 82% |
|
Cost
Paid out of pocket
Cost of Dexmethylphenidate
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
1 | 11% |
|
$25-49 |
5 | 56% |
|
< $25 |
3 | 33% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 28, 2012.